In the central nervous system (CNS), APP can be cleaved to generate the amyloid-β peptide (Aβ), which forms oligomers and amyloid plaques that accumulate in the limbic and cerebral cortices of Alzheimer's disease (AD) patients. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.